©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Meeting Coverage:

Glaucoma 360 New Horizons Forum

Glaucoma 360: 2017

Venture Capital's Transformative Role in Glaucoma

Emmett Cunningham Jr, MD, PhD, MPH, Steven Vold, MD

Show Description +

Emmett Cunningham Jr, MD, PhD, MPH, talks with Steven Vold, MD, about the role of venture capital in transforming the glaucoma space. A key example Dr. Cunningham cites is the development of microinvasive glaucoma surgery or MIGS.

Posted: 2/03/2017

Up Next

OCT Technology: Past, Present, and Future
OCT Technology: Past, Present, and Future

Joel Schuman, MD

Telemedicine and Artificial Intelligence in Glaucoma
Telemedicine and Artificial Intelligence in Glaucoma

Lama Al-Aswad, MD, MPH, Steven Vold, MD

FDA Perspective on the Field of Glaucoma
FDA Perspective on the Field of Glaucoma

Richard Lewis, MD

MIGS: Where We Are and Where We're Going
MIGS: Where We Are and Where We're Going

Steven Vold, MD, Thomas Samuelson, MD

link-arrow   Back to All Videos

Venture Capital's Transformative Role in Glaucoma

Emmett Cunningham Jr, MD, PhD, MPH, Steven Vold, MD

Emmett Cunningham Jr, MD, PhD, MPH, talks with Steven Vold, MD, about the role of venture capital in transforming the glaucoma space. A key example Dr. Cunningham cites is the development of microinvasive glaucoma surgery or MIGS.

Posted: 2/03/2017

Please log in to leave a comment.

More From Glaucoma 360: 2017 Coverage

FDA Perspective on the Field of Glaucoma
FDA Perspective on the Field of Glaucoma

Richard Lewis, MD

MIGS: Where We Are and Where We're Going
MIGS: Where We Are and Where We're Going

Steven Vold, MD, Thomas Samuelson, MD

OCT Technology: Past, Present, and Future
OCT Technology: Past, Present, and Future

Joel Schuman, MD

Telemedicine and Artificial Intelligence in Glaucoma
Telemedicine and Artificial Intelligence in Glaucoma

Lama Al-Aswad, MD, MPH, Steven Vold, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of Glaucoma 360: 2017.

close-x